Bioceres Crop Solutions Corp. BIOX
Company Overview
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Recent Developments
- Jun 2025 Revenue of $333.34M (-28.3% YoY); net profit $-55.42M.
- Trailing 12 Months Year-on-year growth — revenue -35.9%, earnings -1396.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.49% |
| 1 Year: | -35.90% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -1,396.07% |
Stock Price Performance
| 1 Year: | -86.47% |
| 6 Months: | -21.27% |
| 3 Months: | -1.63% |
| 1 Month: | +22.67% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)53.05 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 86.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BIOX Bioceres Crop Solutions Corp. | 0.42 | -0.40 | $26.80M | 0.00% | -0.18% | -18.95% | 0.49% | - |
| 2 | LIN Linde plc NDXSPXR3K | 468.38 | 30.22 | $215.91B | 1.40% | 12.46% | 18.40% | 13.90% | 18.47% |
| 3 | SCCO Southern Copper Corporation R3K | 208.56 | 31.27 | $176.10B | 2.24% | 36.40% | 49.90% | 8.32% | 3.80% |
| 4 | NEM Newmont Corporation SPXR3K | 127.09 | 16.01 | $133.91B | 0.84% | - | 25.91% | 6.53% | 20.15% |
| 5 | RIO Rio Tinto Group | 103.83 | 14.07 | $130.27B | 4.78% | 13.65% | 19.31% | 1.24% | -7.00% |
| 6 | FCX Freeport-McMoRan Inc. SPXR3K | 76.62 | 37.56 | $110.03B | 0.78% | 12.50% | 14.75% | 1.35% | -1.26% |
| 7 | AEM Agnico Eagle Mines Limited | 201.84 | 17.27 | $102.20B | 0.88% | 19.78% | 22.97% | 27.53% | 88.11% |
| 8 | SHW The Sherwin-Williams Company SPXR3K | 326.09 | 30.05 | $79.16B | 1.00% | 21.93% | 65.12% | 6.18% | 8.26% |
| 9 | ECL Ecolab Inc. SPXR3K | 278.11 | 37.33 | $77.96B | 1.05% | 15.10% | 21.96% | 6.55% | 9.74% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 50.10M | 74.37M | 77.44M | 73.67M | 38.20M |
| Cost of Revenue | - | 32.00M | 51.02M | 41.79M | 47.36M | 25.50M |
| Gross Profit | - | 18.10M | 23.35M | 35.64M | 26.31M | 12.70M |
| Operating Expenses | - | 12.70M | 30.26M | 27.88M | 18.49M | 17.50M |
| Operating Income | - | 5.40M | -6.92M | 7.76M | 7.82M | -4.80M |
| EBITDA | - | 14.84M | -32.88M | 9.02M | 6.84M | -7.50M |
| Interest Expense | - | 5.30M | 7.13M | 8.55M | 7.02M | 6.60M |
| Pretax Income | - | -1.20M | -44.92M | -5.37M | -1.37M | -14.10M |
| Tax Provision | - | -3.60M | 6.75M | 2.08M | 3.11M | -4.00M |
| Net Income | - | 2.60M | -47.89M | -7.33M | -183.04M | -9.00M |
| Diluted EPS | - | 0.04 | -0.70 | -0.12 | -2.88 | -0.14 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 328.46M | 419.45M | 464.83M | 333.34M |
| Cost of Revenue | 203.68M | 240.59M | 282.40M | 205.19M |
| Gross Profit | 124.78M | 178.85M | 182.43M | 128.15M |
| Operating Expenses | 80.56M | 125.62M | 138.38M | 128.91M |
| Operating Income | 44.22M | 53.23M | 44.06M | -761.90K |
| EBITDA | 38.20M | 59.73M | 56.49M | -9.76M |
| Interest Expense | 14.95M | 21.23M | 24.12M | 25.63M |
| Pretax Income | 14.06M | 19.11M | 11.07M | -57.57M |
| Tax Provision | 17.97M | -1.07M | 3.78M | 1.27M |
| Net Income | -7.20M | 18.78M | 4.28M | -55.42M |
| Diluted EPS | -0.17 | 0.30 | 0.05 | -0.83 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Total Assets | 518.22M | 818.06M | 852.55M | 763.65M |
| Current Assets | 297.71M | 397.11M | 408.67M | 308.31M |
| Cash & Equivalents | 33.48M | 48.13M | 44.47M | 32.70M |
| Inventory | 126.10M | 140.57M | 126.22M | 89.99M |
| Receivables | 111.75M | 158.01M | 207.32M | 165.86M |
| Total Liabilities | 359.92M | 487.56M | 501.17M | 468.43M |
| Current Liabilities | 222.67M | 298.71M | 329.31M | 337.99M |
| Long Term Debt | 86.74M | 135.88M | 122.91M | 38.20M |
| Total Debt | 169.79M | 257.41M | 270.95M | 276.61M |
| Total Equity | 127.61M | 298.85M | 315.30M | 262.81M |
| Shares Outstanding | 45.87M | 62.80M | 62.85M | 65.63M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | 38.0% | 42.6% | 39.2% | 38.4% |
| Operating Margin % | 13.5% | 12.7% | 9.5% | -0.2% |
| Net Margin % | -2.2% | 4.5% | 0.9% | -16.6% |
| ROE % | -5.6% | 6.3% | 1.4% | -21.1% |
| ROCE % | 15.0% | 10.2% | 8.4% | -0.2% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Solel Partners LP | 7.24% | 4.58M | $1.65M |
| 2 | Mirae Asset Global ETFs Holdings Ltd. | 2.22% | 1.41M | $506.66K |
| 3 | Long Focus Capital Management, LLC | 1.31% | 829.75K | $298.96K |
| 4 | Ardsley Advisory Partners LP | 0.75% | 475.00K | $171.14K |
| 5 | UBS Group AG | 0.65% | 408.28K | $147.10K |
| 6 | Susquehanna International Group, LLP | 0.34% | 212.93K | $76.72K |
| 7 | PNC Financial Services Group, Inc. | 0.21% | 133.00K | $47.92K |
| 8 | Goldman Sachs Group Inc | 0.20% | 129.44K | $46.64K |
| 9 | Ping Capital Management, Inc. | 0.09% | 55.00K | $19.82K |
| 10 | Jane Street Group, LLC | 0.06% | 36.27K | $13.07K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BIOX
BIOX News | BIOCERES CROP SOLUTIONS CORP (NASDAQ:BIOX) - ChartMill
<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE9nWHFuMGFEMFpfbWJlZmFMbmo3NXRscXhyYUhwQVphZVZxTVNINDVvdTdrT0VWV1AyQWJNRW9Tbkl4OEtmRFVGajFicDh1czRlTzlLQkVRelhaVkE?oc=5" target="_blank">BIOX News | BIOCERES CROP SOLUTIONS CORP (NA…
Investors Don't See Light At End Of Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Tunnel And Push Stock Down 54% - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQOHgzNDloZENVV1gzTmlkSl9IMGwzMF84WjdYSGNxV2xOY0dRSGgyLTFONVItU2F4SEE2M1o0SVJjTkgzbzBYMjdqeThsN2c0NlRCMEo5eURrS2VVeDYweERVU0o0NmRJRnVQQk83MTZTekRJYTdDb3VSMXlvOWMwMlpJUUNDZFpUQWc3dH…
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPNEFzbzhDR1ZzSDhDZ213MDdkM3p4YmJ1VFFGb0hWa004d0pUa0tJd0dsTXNjWU84eTl1Z3VDLTNTMW4wREhGbV9XWVo5c245OElmeFQ5WmhNVG1oR1VkeHNfVjNicm9OVHV0OUFMLWs5NGVjUTYtY0ZDemVSeG1tbmJ2bUZkbFlWOGtQUW…
Foreclosure and $179M loss leave this crop firm facing going-concern doubts - Stock Titan
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPcUpNenNudzNWYUtwa3lEcHRzMWM4MnV2RzVEQ0xhSEtZQmF5MlprWDU1N2ZwVHhUVldzZFlId0lFZEN1amhndjd2Qk9nTWFwVTYxWXZJejBxTU5qUlRISXJ6NC13WmdXdmdGTG85T3lnSnhpY0RrUEdidGJnQ3dYbXEzV09vZzBXQUF0Mn…
Price to book forward of Bioceres Crop Solutions Corp. – NASDAQ:BIOX - tradingview.com
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOSkVGdUJEQ2d0OHZMSHllT2FLMDV0d0RqakdpenNaSm55YXNGS2FjTnREYk5fclFPUG1QYTR3NXhjVkw1Rl92VTBYSFhiT3k5VHB1NmFKb295OTZFUjlNYy1rWjFIRDdtelcyel9UckRGaDRwc3RPdzVHSDZGanhaa2dNRGFUZ2I4Tzk3aj…
Bioceres Crop Solutions (BIOX) CEO reports 130,000-share bona fide gift via trust - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQaHFDSDNsXzM5VEJlNnhidTNncE83cUJGeUFnczhaRUdpa1FjVnlXRi03R0h4RlNmUFIzTHgwTm9WMWRRa0dEaEg5cjdMSVQtTmZFbDlZR010REx3V2U2T210VTRiaEZBQ205YTlvcnBTWUVWRHd5VTZXenVuS0JSdTBSS1pLcUlmcE1icU…
BIOX — Frequently Asked Questions
What is the current share price of Bioceres Crop Solutions Corp. (BIOX)?
As of 2026-09-19 21:16 PDT, Bioceres Crop Solutions Corp. (BIOX) trades at $0.42 on NasdaqGS. Its 52-week range is $0.32 to $3.12.
What is the market capitalisation of BIOX?
Bioceres Crop Solutions Corp. (BIOX) has a market capitalisation of $26.80M on NasdaqGS.
What is the P/E ratio of BIOX?
BIOX trades at a trailing price-to-earnings (P/E) ratio of -0.40. The industry average P/E is 22.16. Its price-to-book (P/B) ratio is 0.40.
What is the return on equity (ROE) of BIOX?
BIOX has a return on equity (ROE) of -18.95%. Its return on capital employed (ROCE) is -0.18%.
Is BIOX a good stock to buy?
This page provides a data-driven analysis of Bioceres Crop Solutions Corp. (BIOX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.